AI&II COVID-19 call for urgent research funding (April 2020) - closed
The SARS-CoV-2 pandemic is dramatically affecting the Amsterdam UMC, the Netherlands, and the world. More insights into the pathogenesis, diagnosis, treatment or prevention of COVID-19 are urgently required. Within the Amsterdam Infection and Immunity Institute (AI&II) we have valuable expertise that can be combined to help generate valuable new insights in all of these areas. Therefore, the Infectious Disease Program of AI&II launches the AI&II COVID-19 call for urgent research funding to enable teams of researchers within the Amsterdam UMC and their strategic partners to rapidly pursue innovative studies to fight the ongoing pandemic.
Up to €20.000. Eligible costs are materials, reagents, consumables and analytical support. Funds must be spent within 3 months of funding. Applicants must agree to make an in-kind contribution to the cost of the proposed project (this can be the salaries of research personnel or necessary supplies). We envision funding 2-3 proposals, depending on the number and quality of proposals.
We want to stimulate interdisciplinary research. Therefore, proposals submitted to this call must involve a collaboration between at least two different departments within the Amsterdam UMC or strategic partners (GGD, Sanquin, Reade), with at least one Amsterdam UMC PI/ group leader who is a registered member of AI&II. Additional national and international partners are allowed.
Proposals on any topic related to the pathogenesis, diagnosis, treatment, or prevention of COVID-19 are eligible. This includes basic research, translational, clinical and epidemiological studies. Proposals will be judged on importance for combatting the pandemic and innovativeness.
- Proposal submission deadline: 17 April 2020, 17:00 hrs
- Funding decisions announced: 24 April 2020
- Funding starts: 1 May 2020
- Entire budget must be spent: 31 July 2020
- Final report on project outcomes: 15 August 2020